(Q41131490)

reason for preferred rank

27 September 2017

Lithium in Tricyclic-Resistant Depression Correlation of Increased Brain 5-HT Function with Clinical Outcome (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

23 October 2022

Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659918

23 October 2022

author name string

McCance SL

2

1 reference

27 September 2017

P. J. Cowen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659918

23 October 2022

S. L. McCance

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659918

23 October 2022

C. J. Ware

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659918

23 October 2022

P. R. Cohen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659918

23 October 2022

J. S. Chalmers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659918

23 October 2022

D. L. Julier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1659918

23 October 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

full work available at URL

27 September 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000024806

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

British Journal of Psychiatry

23 October 2022

published in

1 reference

27 September 2017

159

1 reference

27 September 2017

341-346

1 reference

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders

27 September 2017

1

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression

23 October 2022

2

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression

23 October 2022

3

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.

23 October 2022

4

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

23 October 2022

5

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine.

23 October 2022

6

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Possible involvement of presynaptic 5-HT autoreceptors in effect of lithium on 5-HT release in hippocampus of rat

23 October 2022

7

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

L-Tryptophan and prolactin release: Evidence for interaction between 5-HT1 and 5-HT2 receptors

23 October 2022

8

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Recent views on the role of 5-hydroxytryptamine in depression

23 October 2022

9

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Psychotropic drugs and human 5-HT neuroendocrinology

23 October 2022

10

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Clomipramine enhances prolactin and growth hormone responses to L-tryptophan.

23 October 2022

11

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Lithium Increases Serotonin Release and Decreases Serotonin Receptors in the Hippocampus

23 October 2022

12

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin.

23 October 2022

13

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Pindolol decreases prolactin and growth hormone responses to intravenousL-tryptophan

23 October 2022

14

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.

23 October 2022

15

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat.

23 October 2022

16

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

A rating scale for depression

23 October 2022

17

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology

23 October 2022

18

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

A review of the biochemical and neuropharmacological actions of lithium

23 October 2022

19

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Lithium increases 5-HT-mediated prolactin release.

23 October 2022

20

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Blunted growth hormone and prolactin responses to L-tryptophan in depression; a state-dependent abnormality

23 October 2022

21

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature

23 October 2022

22

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Lithium and serotonin function: implications for the serotonin hypothesis of depression

23 October 2022

23

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Neuroendocrine responses to intravenous tryptophan in major depression.

23 October 2022

24

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Desipramine treatment in normal subjects. Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors.

23 October 2022

25

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Variability of response to lithium augmentation in refractory depression

23 October 2022

26

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation

23 October 2022

27

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Differential effects of short and long term lithium on tryptophan uptake and serotonergic function in cat brain

23 October 2022

29

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Duration of antidepressant drug treatment. What is an adequate trial?

23 October 2022

30

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate

23 October 2022

33

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

23 October 2022

34

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man

23 October 2022

35

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

5-HT neuroendocrine responses during psychotropic drug treatment: an investigation of the effects of lithium

23 October 2022

36

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS.

23 October 2022

37

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization

23 October 2022

38

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Luteinizing hormone responses to luteinizing hormone releasing hormone (LHRH) in acute mania and the effects of lithium on LHRH and thyrotrophin releasing hormone tests in volunteers

23 October 2022

39

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

The biochemistry of affective disorders

23 October 2022

40

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.

23 October 2022

41

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.

23 October 2022

42

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism

23 October 2022

43

1 reference

https://api.crossref.org/works/10.1192/BJP.159.3.341

23 October 2022

Identifiers

1 reference

27 September 2017

1 reference